Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Overall Survival Following Interval and Delayed Cytoreduction Surgery in Advanced Stage Ovarian Cancer: a Pragmatic Phase III Randomised Controlled Trial

NCT07068464 is registered in ClinicalTrials.gov with NHS Grampian as lead sponsor.

NCT NCT07068464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07068464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Overall Survival Following Interval and Delayed Cytoreduction Surgery in Advanced Stage Ovarian Cancer: a Pragmatic Phase III Randomised Controlled Trial
Lead sponsor
NHS Grampian
Phase
Phase 3
Overall status
Not yet recruiting
Start date
January 31, 2026
Completion date
January 31, 2034
Enrollment
682 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovary cancer